Purchases and Sales Made in Q3 2024 in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during Q3 2024. The information is specifically focused on institutions that hold shares of Adaptimmune Therapeutics PLC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-130K- 7.26% |
$119K - $180K
|
1.66M
$348K
|
|
|
Nov 14, 2024
Q3 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-519K- 4.94% |
$478K - $722K
|
10M
$2.1M
|
|
|
Nov 14, 2024
Q3 2024
|
Matrix Capital Management Company, LP
Waltham, MA |
SELL
|
- |
-1.29M- 3.32% |
$1.19M - $1.8M
|
37.7M
$7.91M
|